title: [Non-small-cell bronchial cancers: improvement of survival probability by conformal radiotherapy].
abstract: The conformal radiotherapy approach, three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT), is based on modern imaging modalities, efficient 3D treatment planning systems, sophisticated immobilization devices and demanding quality assurance and treatment verification. The main goal of conformal radiotherapy is to ensure a high dose distribution tailored to the limits of the target volume while reducing exposure of healthy tissues. These techniques would then allow a further dose escalation increasing local control and survival. Non-small cell lung cancer (NSCLC) is one of the most difficult malignant tumors to be treated. It combines geometrical difficulties due to respiratory motion, and number of low tolerance neighboring organs, and dosimetric difficulties because of the presence of huge inhomogeneities. This localization is an attractive and ambitious example for the evaluation of new techniques. However, the published clinical reports in the last years described very heterogeneous techniques and, in the absence of prospective randomized trials, it is somewhat difficult at present to evaluate the real benefits drawn from those conformal radiotherapy techniques. After reviewing the rationale for 3DCRT for NSCLC, this paper will describe the main studies of 3DCRT, in order to evaluate its impact on lung cancer treatment. Then, the current state-of-the-art of IMRT and the last technical and therapeutic innovations in NSCLC will be discussed.
authors.affiliation: Département d'oncologie-radiothérapie, institut Curie, 26, rue d'Ulm, 75005 Paris, France. philippe.giraud@curie.net
authors.forename: P
authors.initials: P
authors.lastname: Giraud
authors.forename: S
authors.initials: S
authors.lastname: Helfre
authors.forename: A
authors.initials: A
authors.lastname: Lavole
authors.forename: J C
authors.initials: JC
authors.lastname: Rosenwald
authors.forename: J M
authors.initials: JM
authors.lastname: Cosset
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004307:Dose-Response Relationship, Radiation; D005240:Feasibility Studies; D006801:Humans; D021621:Imaging, Three-Dimensional; D008175:Lung Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011379:Prognosis; D011832:Radiation Injuries / Q000453:epidemiology / Q000209:etiology; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D020266:Radiotherapy, Conformal / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016896:Treatment Outcome